Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia

International Journal of Gynecology and Obstetrics

Volumn 98, Issue 2, 2007, Pages 105-109

  Hwang, H S ^a   Kwon, J Y ^a   Kim, M A ^a   Park, Y W ^a   Kim, Y H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

C reactive protein; Highly sensitive C reactive protein; Mean arterial pressure; Pre eclampsia; Time to diuresis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; DISEASE SEVERITY; DIURESIS; FEMALE; HUMAN; IMMUNOPHELOMETRY; MATERNAL SERUM; MEAN ARTERIAL PRESSURE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; UTERINE ARTERY;

EID: 34447290480     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.03.050     Document Type: Article

References (25)

1. Rebelo I., Carvalho-Guerra F., Pereira-Leite L., and Quintanilha A. Lactoferrin as a sensitive blood marker of neutrophil activation in normal pregnancies. Eur J Obstet Gynecol Reprod Biol 62 (1995) 189-194
2. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 20 (1998) 2007-2011
3. Loukovaara M.J., Alfthan H.V., Kurki M.T., Hiilesmaa V.K., and Andersson S.H.M. Serum highly sensitive C-reactive protein in preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 110 (2003) 26-28
4. Hvilsom G.B., Thorsen P., Jeune B., and Bakketeig L.S. C-Reactive protein: a serological marker for preterm delivery?. Acta Obstet Gynecol Scand 81 (2002) 424-429
5. Djurovic S., Clausen T., Wergeland R., Brosstad F., Berg K., and Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 109 (2002) 759-764
6. Watts D.H., Krohn M.A., Wener M.H., and Eschenbach D.A. C-reactive protein in normal pregnancy. Obstet Gynecol 77 2 (1991) 176-180
7. Yu H., and Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem 8 (2000) 601-610
8. Larsson A., and Hansson L.O. High sensitivity CRP and serum amyloid A as expressions of low grade inflammation do not correlate with bFGF or VEGF. Ups J Med Sci 108 (2003) 51-59
9. American College of Obstetricians and Gynecologists. Hypertension in pregnancy (1996), ACOG, Washington, DC Technical Bulletin no. 219
10. Wang Y., Gu Y., Zhang Y., and Lewis D.F. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 3 (2004) 817-824
11. Kharb S., Gulati N., Singh V., and Singh G.P. Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 46 (1998) 238-240
12. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., and Socol M.L. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 3 (1996) 420-427
13. Teran E., Escudero C., Moya W., Flores M., Vallance P., and Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynecol Obstet 3 (2001) 243-249
14. Qiu C., Luthy D.A., Zhang C., Walsh S.W., Leisenring W.M., and Williams M.A. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 17 (2004) 154-160
15. Ustun Y., Engin-Ustun Y., and Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 121 2 (Aug 1 2005) 154-158
16. Fontenot M.T., Lewis D.F., Frederick J.B., Wang Y., DeFranco E.A., Groome L.J., et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. Am J Obstet Gynecol 192 6 (2005) 1788-1793
17. Li H., Gudnason H., Olofsson P., Dubiel M., and Gudmundsson S. Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one-third of late third-trimester pre-eclamptic women. Ultrasound Obstet Gynecol 25 5 (May 2005) 459-463
18. Park Y.W., Lim J.C., Kim Y.H., and Kwon H.S. Uterine artery Doppler velocimetry during mid-second trimester to predict complications of pregnancy based on unilateral or bilateral abnormalities. Yonsei Med J 46 5 (Oct 31 2005) 652-657
19. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. Int J Gynecol Obstet 77 (2002) 67-75 [ACOG practice bulletin]
20. Belo L., Santos-Silva A., Rocha S., Caslake M., Cooney J., Pereira-Leite L., et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 123 (2005) 46-51
21. Sacks G.P., Seyani L., Lavery S., and Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 19 (2004) 1025-1030
22. Romem Y., and Artal R. C-Reactive protein in pregnancy and in the postpartum period. Am J Obstet Gynecol 151 (1985) 380-383
23. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (1996) 1061-1065
24. Conde-Agudelo A., Villar J., and Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104 (2004) 1367-1391
25. Okerengwo A.A., Williams A.I., and Ibeziako P.A. Immunological studies on preeclampsia in Nigerian women. Int J Gynecol Obstet 33 (1990) 121-125